Estudos de relação estrutura atividade e docking - UFRJ

91______. PDBsum new things. Nucleic Acids Res, v. 37, p. D355-D359, 2009.LASKOWSKI, R. A.; CHISTYAKOV, V. V.; THORNTON, J. M. PDBsum more: new summaries and analysesof the known 3D structures of proteins and nucleic acids. Nucleic Acids Res, v. 33, p. D266-D268, 2005.LASKOWSKI, R. A.; HUTCHINSON, E. G.; MICHIE, A. D.; WALLACE, A. C.; JONES, M. L.;THORNTON, J. M. PDBsum: a Web-based database of summaries and analyses of all PDB structures. TrendsBiochem Sci, v. 22, 12, p. 488-490, 1997.LASKOWSKI, R. A.; MACARTHUR, M. W.; MOSS, D. S.; THORNTON, J. M. PROCHECK: a program tocheck the stereochemical quality of protein structures. Journal of Applied Crystallography, v. 26, 2, p. 283-291, 1993.LASKOWSKI, R. A.; RULLMANNN, J. A.; MACARTHUR, M. W.; KAPTEIN, R.; THORNTON, J. M.AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. JBiomol NMR, v. 8, 4, p. 477-86, 1996.LEACH, A. R. Molecular Modelling: Principles and Applications. Pearson Education Limited 2ª ed., 2001.LEMKE, T. L.; WILLIAMS, D. A. Foye's Principles of Medicinal Chemistry. Lippincott Williams &Wilkins, 6ed ed., 2008.LIANG, P. H.; BRUN, K. A.; FEILD, J. A.; O'DONNELL, K.; DOYLE, M. L.; GREEN, S. M.; BAKER, A. E.;BLACKBURN, M. N.; ABDEL-MEGUID, S. S. Site-directed mutagenesis probing the catalytic role ofarginines 165 and 166 of human cytomegalovirus protease. Biochemistry, v. 37, 17, p. 5923-9, 1998.LILL, M.; DANIELSON, M. Computer-aided drug design platform using PyMOL. J Comput Aided Mol Des,v. 25, 1, p. 13-19, 2011.LIM, M. D.; CRAIK, C. S. Using specificity to strategically target proteases. Bioorg Med Chem, v. 17, 3, p.1094-100, 2009.LIU, F. Y.; ROIZMAN, B. The herpes simplex virus 1 gene encoding a protease also contains within its codingdomain the gene encoding the more abundant substrate. J Virol, v. 65, 10, p. 5149-56, 1991.LUCERO, B.; GOMES, C. R.; FRUGULHETTI, I. C.; FARO, L. V.; ALVARENGA, L.; DE SOUZA, M. C.;DE SOUZA, T. M.; FERREIRA, V. F. Synthesis and anti-HSV-1 activity of quinolonic acyclovir analogues.Bioorg Med Chem Lett, v. 16, 4, p. 1010-3, 2006.LUPI, O. Herpes simples. An. Bras.Dermatol., v. 75 3, p. 261-275, 2000.LUTHY, R.; BOWIE, J. U.; EISENBERG, D. Assessment of protein models with three-dimensional profiles.Nature, v. 356, 6364, p. 83-5, 1992.MA, D.-L.; CHAN, D. S.-H.; LEE, P.; KWAN, M. H.-T.; LEUNG, C.-H. Molecular modeling of drug–DNAinteractions: Virtual screening to structure-based design. Biochimie, v. 93, 8, p. 1252-1266, 2011.MADURGA, S.; BELDA, I.; LLORÀ, X.; GIRALT, E. Design of enhanced agonists through the use of a newvirtual screening method: Application to peptides that bind class I major histocompatibility complex (MHC)molecules. Protein Science, v. 14, 8, p. 2069-2079, 2005.MAMIDYALA, S. K.; FIRESTINE, S. M. Advances in herpes simplex virus antiviral therapies. ExpertOpinion on Therapeutic Patents, v. 16, 11, p. 1463-1480, 2006.MARNETT, A. B.; NOMURA, A. M.; SHIMBA, N.; ORTIZ DE MONTELLANO, P. R.; CRAIK, C. S.Communication between the active sites and dimer interface of a herpesvirus protease revealed by a transitionstateinhibitor. Proc Natl Acad Sci U S A, v. 101, 18, p. 6870-5, 2004.